Cannara Biotech

Cannara Biotech EBIT per Share

The EBIT per Share of Cannara Biotech (LOVE.V) as of Oct 12, 2026 is 0.24 CAD. In the previous year, EBIT per Share was 0.09 CAD — a change of 166.48% (higher).

EBIT per Share

0.24CAD

YoY

166.48%

Last updated:

EBIT per Share of Cannara Biotech is 2025 0.24 CAD. EBIT per Share of Cannara Biotech was 2024 0.09 CAD. It decreases by 166.48% higher compared to the previous year.

The Cannara Biotech EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
0.00 CAD
Jan 1, 2022
0.01 CAD
Jan 1, 2023
0.13 CAD
Jan 1, 2024
0.09 CAD
Jan 1, 2025
0.24 CAD
Jan 1, 2026 (e)
0.22 CAD
Jan 1, 2027 (e)
0.27 CAD
Jan 1, 2028 (e)
0.34 CAD
The Cannara Biotech EBIT per Share history
YEAREBIT per ShareYoY
est0.34CAD+27.76%
est0.27CAD+22.33%
est0.22CAD-7.40%
0.24CAD+166.48%
0.09CAD-32.87%
0.13CAD+2,246.17%
0.01CAD+1,562.04%
0.00CAD-102.11%
-0.02CAD+11.79%
-0.01CAD+452.98%
-0.00CAD—
Access this data via the Eulerpool API
Get Free API Key

Cannara Biotech Stock analysis

What does Cannara Biotech do? Cannara Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cannara Biotech stock

EBIT per Share of Cannara Biotech is 0.24 CAD in 2025.

EBIT per Share of Cannara Biotech changed from 0.09 CAD to 0.24 CAD, representing a 166.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Cannara Biotech since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Cannara Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Cannara Biotech